Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Eosinophilic granulomatosis with polyangiitis

Diseases of the Musculoskeletal System and Connective Tissue

Eosinophilic granulomatosis with polyangiitis is an extremely rare autoimmune condition that causes inflammation of small and medium-sized blood vessels in people with allergic sensitivities. Common manifestations include fatigue, fever, weight loss, night sweats, abdominal pain, cough, joint and muscle pain, skin rashes and general malaise, with the disease progressing through allergic, eosinophilic and vasculitic stages that primarily affect the lungs, digestive tract, heart and peripheral nerves. The exact mechanisms behind the abnormal immune activity targeting blood vessels remain incompletely understood. Pathologists Jacob Churg and Lotte Strauss identified the condition in 1951 at Mount Sinai Hospital in New York City, originally calling it allergic granulomatosis; the modern name removes the eponymous reference, reflecting current medical nomenclature practice.

Facts
Classification
Body System
Cardiovascular System 1
ICD-10 Chapter
XIII: Diseases of the Musculoskeletal System and Connective Tissue 2
Communicable or Non-communicable
Non-Communicable 1
Transmission Route
Non-Transmissible 1
Causative Agent
Causative Agent (category)
Autoimmune 1
First Described
1951 3
Sources
1. Eosinophilic granulomatosis with polyangiitis (Wikipedia)
Wikipedia intro: EGPA: 'autoimmune condition that causes inflammation of small and medium-sized blood vessels'View the Source
2. World Health Organization: ICD-10 Version:2019 - M30.1
World Health OrganizationICD-10 2019 category M30.1, Chapter XIII
Quote, ICD-10 2019 category M30.1, Chapter XIII
M30.1 Polyarteritis with lung involvement [Churg-Strauss]
View the Source
3. Eosinophilic granulomatosis with polyangiitis (Wikipedia)
Wikidata: Eosinophilic granulomatosis with polyangiitis
Wikidata Q32811, class allow-list match (w-wdresolver-0926)View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.